IOP Reduction in Pigmentary Glaucoma Using DSLT
Purpose
This study is a single-site, single-arm, prospective, observational study of IOP reduction after DSLT. Subjects will be assessed up to 12 months post-operatively. Clinical evaluations will include IOP and number of glaucoma medications.
Conditions
- Pigmentary Dispersion Syndrome
- Pigmentary Dispersion Glaucoma
Eligibility
- Eligible Ages
- All ages
- Eligible Sex
- All
- Accepts Healthy Volunteers
- No
Inclusion Criteria
- Adult patients with pigmentary dispersion syndrome with elevated IOP or mild to moderate (based on AAO Preferred Practice Program criteria) pigmentary glaucoma with glaucomatous optic neuropathy and corresponding visual field/RNFL loss. - Treatment naive, or washed out IOP ranging from ≥18-34 mmHg - Central corneal thickness (CCT) 480-600 µm - Able to complete medication washout and follow-up
Exclusion Criteria
- Prior incisional glaucoma surgery or glaucoma-related procedures in the study eye - Prior laser trabeculoplasty <3 years - Prior intraocular surgery and refractive surgery, except for cataract surgery unless greater than 2 years - Patients anticipating cataract surgery within the follow-up period - History of ocular inflammation and infection - All other secondary glaucoma including exfoliative - Patients unable to have DSLT treatment
Study Design
- Phase
- Study Type
- Observational
- Observational Model
- Cohort
- Time Perspective
- Prospective
Recruiting Locations
Mann Eye Institute
Houston, Texas 76134-2099
Houston, Texas 76134-2099
More Details
- Status
- Recruiting
- Sponsor
- Mann Eye Institute